Altimmune Inc (ALT)
7.72
+0.56
(+7.82%)
USD |
NASDAQ |
May 09, 16:00
7.79
+0.07
(+0.91%)
Pre-Market: 08:29
Altimmune Gross Profit (Quarterly)
Gross Profit (Quarterly) Chart
Historical Gross Profit (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2011 | 5.260M |
| June 30, 2011 | 6.429M |
| March 31, 2011 | 6.338M |
| December 31, 2010 | |
| September 30, 2010 | 6.244M |
| June 30, 2010 | 4.780M |
| Date | Value |
|---|---|
| March 31, 2010 | 3.117M |
| December 31, 2009 | 7.126M |
| September 30, 2009 | 6.830M |
| June 30, 2009 | 8.071M |
| March 31, 2009 | 5.522M |
Gross Profit Definition
Gross profit is the difference between sales and the cost of goods sold. Revenues (aka Sales) less Cost of Goods Sold (COGS) is a company's gross profit. For many companies, cost of goods sold is a substantial portion of expenses.
Gross Profit (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Gross Profit (Quarterly) Benchmarks
| Eli Lilly and Co | 7.094B |
| Amgen Inc | 4.247B |
| Pfizer Inc | 11.50B |
| Viking Therapeutics Inc | -- |
| Precision BioSciences Inc | -- |